Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfusion of granulocytes for patients with febrile neutropenia
DRKS00000218Phase 3Withdrawn
- Sponsor
- University of Cologne
- Start
- May 2011
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3 trial of granulocyte transfusion in febrile neutropenia (FN), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and 8 more (2 arms), sponsored by University of Cologne. Planned start May 2011; status: withdrawn.
02
Drugs
granulocyte transfusion
03
Conditions
febrile neutropenia (FN)acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on DRKS00000218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000218.